Biotech

Startups News

Biotech Startups Essentials publishes only the best Biotech news and links, carefully hand-picked and curated by top biotech experts.

Biotech

Top news of the week: 07.06.2022.

Medicine
Biotechnology
Dot-com bubble
Therapy
Pharmacology
Drug

@BiotechWorld shared
On Jun 1, 2022
Biotech, Pharma Companies Team Up to Fight Diabetes, Alzheimer’s and Cancer https://t.co/AtzUzji5ri https://t.co/rsDu0SUqDI
Open
Biopharma Companies Team Up to Fight Diabetes, Alzheimer’s and Cancer

Biopharma Companies Team Up to Fight Diabetes, Alzheimer’s and Cancer

Several new biotech and biopharma agreements involving companies are sharing their strengths to develop new treatments for high-need diseases diabetes, Alzheimer’s and cancer.

@BiotechWorld shared
On Jun 1, 2022
Amgen and NSG Biolabs Announce Golden Ticket to Boost Singapore's Biotech Ecosystem https://t.co/sKDHuOeMIK
Open
Amgen and NSG Biolabs Announce Golden Ticket to Boost Singapore's Biotech Ecosystem

Amgen and NSG Biolabs Announce Golden Ticket to Boost Singapore's Biotech Ecosystem

Amgen and NSG Biolabs Announce Golden Ticket to Boost Singapore's Biotech Ecosystem - read this article along with other careers information, tips and advice on BioSpace

@BentheFidler shared
On Jun 2, 2022
Former AbbVie executive Severino joins Flagship-backed startup as CEO https://t.co/0gaRdOO2Pm by @NedPagliarulo @FlagshipPioneer $ABBV #startups
Open
Former AbbVie executive Severino joins Flagship-backed startup as CEO

Former AbbVie executive Severino joins Flagship-backed startup as CEO

Severino left the pharma company in April after eight years as its chief scientist and then president. He'll lead Tessera Therapeutics, a well-funded genetic medicine startup.

@BentheFidler shared
On Jun 2, 2022
Upstream Bio, a richly funded startup, reveals its lead drug and research plans https://t.co/83pEUDGoM9 by @NedPagliarulo #startups #biotech @atlasventure $AMGN $ALPMY
Open
Upstream Bio, a richly funded startup, reveals its lead drug and research plans

Upstream Bio, a richly funded startup, reveals its lead drug and research plans

Backed by $200 million in funding and led by biotech veteran Samantha Truex, Upstream is developing a clinical-stage inflammatory disease drug acquired from Astellas last year.

@rtnarch shared
On Jun 6, 2022
Resilience announces $625M Series D. https://t.co/ZKQXWxZ8sV
Open
Resilience Announces $625 Million Series D Financing to Expand Network, Bring Innovative Technologies to Biomanufacturing

Resilience Announces $625 Million Series D Financing to Expand Network, Bring Innovative Technologies to Biomanufacturing

National Resilience, Inc. (Resilience), a technology-focused biomanufacturing company dedicated to broadening access to complex medicines, today annou

@FlagshipPioneer shared
On Jun 2, 2022
Flagship General Partner @AvakK explains the power of asking “What if” in Flagship’s unique approach to #bioplatform company creation, including in launching @ProFoundTx and discovering a whole universe of new, undiscovered proteins in the human body. https://t.co/yq9dF8qZGs https://t.co/koeTNgl031
Open
Flagship's creative approach to finding the next big idea in biopharma

Flagship's creative approach to finding the next big idea in biopharma

Avak Kahvejian, partner at Flagship Pioneering, a company that conceives, creates and launches bioplatform companies like Moderna, discusses its latest venture, ProFound Therapeutics.

@PearlF shared
On Jun 2, 2022
Here's the Boston Globe story on Upstream Bio & asthma drug by @RLCscienceboss https://t.co/srSFV6E4jn
Open
Upstream Bio raises $200 million to develop treatment for severe asthma

Upstream Bio raises $200 million to develop treatment for severe asthma

The Waltham startup acquired the experimental antibody therapy from Japanese drug maker Astellas.

@BiotechWorld shared
On Jun 2, 2022
Vazyme Releases 2021 Annual Report: Announces More Efforts in Technology innovation and Together with Partners for a Better Future https://t.co/uzkhPYtnoS
Open
Vazyme Releases 2021 Annual Report: Announces More Efforts in Technology innovation and Together with Partners for a Better Future

Vazyme Releases 2021 Annual Report: Announces More Efforts in Technology innovation and Together with Partners for a Better Future

Vazyme Releases 2021 Annual Report: Announces More Efforts in Technology innovation and Together with Partners for a Better Future - read this article along with other careers information, ...

Read more:
weekly 07.06.2022
View archives
Back to home

Subscribe to Biotech - Startups.

Avoid an information overload and get the most trusted industry news hand-picked by the top Experts. Sign up for the weekly Biotech - Startups.
Privacy Policy

Sign up for the weekly Biotech - Startups newsletter

Never again miss anything or anyone that matter in Biotech

Sign up and receive the Biotech - Startups weekly email newsletter directly to your inbox. Make more informed business decisions based on insight for the most trusted industry experts, faster.
Privacy Policy